Noé V - Search Results

1

Synthesis and validation of DOPY: A new gemini dioleylbispyridinium based amphiphile for nucleic acid transfection.

Aubets E, Griera R, Felix AJ, Rigol G, Sikorski C, Limón D, Mastrorosa C, Busquets MA, Pérez-García L, Noé V, Ciudad CJ. Aubets E, et al. Among authors: noe v. Eur J Pharm Biopharm. 2021 Aug;165:279-292. doi: 10.1016/j.ejpb.2021.05.016. Epub 2021 May 24. Eur J Pharm Biopharm. 2021. PMID: 34033881 Free article.

2

Development and effects of immunoliposomes carrying an antisense oligonucleotide against DHFR RNA and directed toward human breast cancer cells overexpressing HER2.

Rodríguez M, Coma S, Noé V, Ciudad CJ. Rodríguez M, et al. Among authors: noe v. Antisense Nucleic Acid Drug Dev. 2002 Oct;12(5):311-25. doi: 10.1089/108729002761381294. Antisense Nucleic Acid Drug Dev. 2002. PMID: 12477281

3

Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F.

Nicolás M, Noé V, Ciudad CJ. Nicolás M, et al. Among authors: noe v. Biochem J. 2003 Apr 15;371(Pt 2):265-75. doi: 10.1042/BJ20021166. Biochem J. 2003. PMID: 12513689 Free PMC article.

4

Inhibition of CD4 expression by antisense oligonucleotides in PMA-treated lymphocytes.

Rabanal M, Franch A, Noé V, Ciudad CJ, Castell M, Castellote C. Rabanal M, et al. Among authors: noe v. Antisense Nucleic Acid Drug Dev. 2002 Dec;12(6):399-410. doi: 10.1089/108729002321082474. Antisense Nucleic Acid Drug Dev. 2002. PMID: 12568314

5

An intron is required for dihydrofolate reductase protein stability.

Noé V, MacKenzie S, Ciudad CJ. Noé V, et al. J Biol Chem. 2003 Oct 3;278(40):38292-300. doi: 10.1074/jbc.M212746200. Epub 2003 Jul 15. J Biol Chem. 2003. PMID: 12865433 Free article.

6

The expression of retinoblastoma and Sp1 is increased by low concentrations of cyclin-dependent kinase inhibitors.

Peñuelas S, Alemany C, Noé V, Ciudad CJ. Peñuelas S, et al. Among authors: noe v. Eur J Biochem. 2003 Dec;270(24):4809-22. doi: 10.1046/j.1432-1033.2003.03874.x. Eur J Biochem. 2003. PMID: 14653808 Free article.

7

CD4 expression decrease by antisense oligonucleotides: inhibition of rat T CD4+ cell reactivity.

Rabanal M, Franch A, Noé V, Pelegrí C, Ciudad CJ, Castellote C, Castell M. Rabanal M, et al. Among authors: noe v. Oligonucleotides. 2003;13(4):217-28. doi: 10.1089/154545703322460603. Oligonucleotides. 2003. PMID: 15000837

8

Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages.

Llaverias G, Noé V, Peñuelas S, Vázquez-Carrera M, Sánchez RM, Laguna JC, Ciudad CJ, Alegret M. Llaverias G, et al. Among authors: noe v. Biochem Biophys Res Commun. 2004 May 21;318(1):265-74. doi: 10.1016/j.bbrc.2004.04.021. Biochem Biophys Res Commun. 2004. PMID: 15110783

9

Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.

Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J, Ciudad CJ. Coma S, et al. Among authors: noe v. Oligonucleotides. 2004;14(2):100-13. doi: 10.1089/1545457041526290. Oligonucleotides. 2004. PMID: 15294074

10

Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.

Llaverias G, Vázquez-Carrera M, Sánchez RM, Noé V, Ciudad CJ, Laguna JC, Alegret M. Llaverias G, et al. Among authors: noe v. J Lipid Res. 2004 Nov;45(11):2015-24. doi: 10.1194/jlr.M400049-JLR200. Epub 2004 Aug 16. J Lipid Res. 2004. PMID: 15314095 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters